Related Experiment Video
Updated: Nov 19, 2025
09:39
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
15.7K
Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy
Cuauhtli N Azotla-Vilchis1,2, Daniel Sanchez-Celis1,2, Luis E Agonizantes-Juárez1,3
1Laboratory of Genomic Medicine, Department of Genetics, Instituto Nacional de Rehabilitación, Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.
Biomolecules
|February 3, 2021
Summary
Myotonic dystrophy type 1 (DM1) brain pathology involves altered glial cell immune responses. This study developed a new DM1 glial cell model to investigate these changes, revealing inflammation as a key deregulated process.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Myotonic dystrophy type 1 (DM1) is a frequent inherited muscular dystrophy linked to CTG repeat expansion in the DMPK gene.
- DM1 causes multisystemic issues, including central nervous system (CNS) alterations, with glial cell involvement suspected but not fully understood.
Purpose of the Study:
- To investigate the molecular and cellular effects of the DM1 mutation on glial physiology.
- To establish a novel inducible DM1 glial cell model for studying disease mechanisms.
Main Methods:
- Developed an inducible DM1 model using MIO-M1 cells with 648 CUG repeats.
- Utilized a microarray whole-transcriptome approach to analyze gene expression changes.
- Performed gene ontology enrichment analysis.
Main Results:
- The DM1 model recapitulated key DM1 hallmarks: nuclear RNA foci, MBNL protein colocalization, and alternative splicing dysregulation.
- Identified significant gene expression changes, including immune mediators (CXCL10, CCL5, CXCL8, TNFAIP3, TNFRSF9) and microRNAs (miR-222, miR-448).
- Gene ontology analysis highlighted inflammation and immune response as major deregulated processes in DM1 glial cells.
Conclusions:
- DM1 mutation in glial cells leads to an altered immune response.
- Glial cells may contribute to CNS pathology in DM1.
- This study provides a new model for investigating DM1 glial cell dysfunction and potential therapeutic targets.
